Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately to Severely Active Ulcerative Colitis”

180 trials

Showing 20 of 180 results

Testing effectiveness (Phase 2)Ended earlyNCT04987307
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 221
Not applicableLooking for participantsNCT06764706
What this trial is testing

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 200
Testing effectiveness (Phase 2)Looking for participantsNCT07083193
What this trial is testing

AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Accro Bioscience (Suzhou) Limited 24
Testing effectiveness (Phase 2)Looking for participantsNCT06764615
What this trial is testing

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda 183
Testing effectiveness (Phase 2)Study completedNCT05570006
What this trial is testing

Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 30
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Large-scale testing (Phase 3)Study completedNCT00488631
What this trial is testing

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 1,228
Large-scale testing (Phase 3)Study completedNCT02165215
What this trial is testing

The Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Colitis, Ulcerative
Hoffmann-La Roche 359
Testing effectiveness (Phase 2)Looking for participantsNCT07035041
What this trial is testing

D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
UC - Ulcerative ColitisModerately to Severely Active Ulcerative Colitis
InventisBio Co., Ltd 120
Testing effectiveness (Phase 2)Study completedNCT01988961
What this trial is testing

Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 103
Testing effectiveness (Phase 2)Study completedNCT03093259
What this trial is testing

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 32
Testing effectiveness (Phase 2)Looking for participantsNCT05287126
What this trial is testing

Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 36
Large-scale testing (Phase 3)Study completedNCT02065622
What this trial is testing

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 952
Early research (Phase 1)Study completedNCT02818686
What this trial is testing

TD-1473 for Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Theravance Biopharma 40
Testing effectiveness (Phase 2)WithdrawnNCT04096573
What this trial is testing

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
LG Chem
Testing effectiveness (Phase 2)Looking for participantsNCT07374471
What this trial is testing

MB-001 in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Mage Biologics 100
Large-scale testing (Phase 3)Study completedNCT04706793
What this trial is testing

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

Who this might be right for
Ulcerative Colitis
Pfizer 42
Testing effectiveness (Phase 2)Looking for participantsNCT06619990
What this trial is testing

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Xencor, Inc. 270
Testing effectiveness (Phase 2)Study completedNCT03178669
What this trial is testing

The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
InDex Pharmaceuticals 213
Not applicableEnded earlyNCT05069259
What this trial is testing

Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

Who this might be right for
Ulcerative Colitis
Pfizer 18
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation